SC 13D Filing

Company

ADMA BIOLOGICS, INC.

Filed

August 9, 2018

Accession Number

0001123292-18-000893

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →